Clinical Trials Logo

Clinical Trial Summary

Intrauterine growth restriction refers to a fetus that has failed to get a specific measures by a gestational age. Asymmetric type of Intrauterine growth restriction is known by normal sized head with smaller abdomen.It is important to recognize the growth restricted fetuses, because these fetuses may have fetal or neonatal complications.

When blood flow is increased, the oxygen and nutrients will deliver good to the fetus. The role of low-dose aspirin therapy in management of intrauterine growth restriction is controversial. It has been used, in many studies, in prevention of intrauterine growth restriction especially in women at high risk of pre-eclampsia or obstetrical antiphospholipid syndrome.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03038607
Study type Interventional
Source Assiut University
Contact
Status Completed
Phase Phase 2
Start date January 2016
Completion date January 2017

See also
  Status Clinical Trial Phase
Recruiting NCT03321292 - L-arginine in Treatment of Intrauterine Growth Restriction N/A